Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Agricultural planting improvement and risk control.

Frontiers in bioengineering and biotechnology·2025
Same author

Helping students see bacteria in 3D: cellular models increase student learning about cell size and diffusion.

Journal of microbiology & biology education·2023
Same author

Novel approaches to circumvent the devastating effects of pests on sugarcane.

Scientific reports·2021
Same author

Editorial: Sustainable Development Goals (SDGs): Impact on Nutrition.

Frontiers in nutrition·2021
Same author

COVID-19 Testing Tests Our Mettle.

Missouri medicine·2020
Same author

Flawed scientific studies block progress and sow confusion.

GM crops & food·2020
Same journal

Patent highlights December 2023-January 2024.

Pharmaceutical patent analyst·2025
Same journal

Sulfopropanoic acid derivatives for treating neurodegenerative disorders: a patent spotlight.

Pharmaceutical patent analyst·2025
Same journal

Patent highlights April-May 2024.

Pharmaceutical patent analyst·2025
Same journal

Patent highlights June - July 2024.

Pharmaceutical patent analyst·2025
Same journal

Patent highlights February-March 2024.

Pharmaceutical patent analyst·2025
Same journal

Trispecific anti-CLDN-18.2/CD3/CD28 antibodies for gastric cancer treatment.

Pharmaceutical patent analyst·2025
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
11:08

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Published on: April 8, 2012

34.9K

Virus expression vectors.

Kathleen L Hefferon1

  • 1Cornell University, Ithaca, NY, 14853, USA.

Pharmaceutical Patent Analyst
|July 8, 2014
PubMed
Summary
This summary is machine-generated.

Recent advancements in virus expression vectors offer improved gene delivery, cancer therapy, and vaccine development. These next-generation vectors enhance tissue specificity and expression while improving safety and reducing immunogenicity for medical research applications.

More Related Videos

An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector
10:13

An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector

Published on: January 12, 2018

8.1K
Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

9.6K

Related Experiment Videos

Last Updated: Apr 27, 2026

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
11:08

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Published on: April 8, 2012

34.9K
An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector
10:13

An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector

Published on: January 12, 2018

8.1K
Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

9.6K

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Virology

Background:

  • Virus expression vectors have been utilized for gene delivery, cancer therapy, and vaccine development for many years.
  • Previous generations of virus vectors faced limitations regarding immunogenicity and safety.

Purpose of the Study:

  • To review recent patents in the field of virus expression vector development.
  • To cover innovations in both plant and animal virus expression vectors.
  • To discuss future prospects of virus expression vectors in medical research.

Main Methods:

  • Literature review of recent patents.
  • Analysis of innovations in plant and animal virus expression vectors.

Main Results:

  • Next-generation virus vectors exhibit enhanced tissue specificity and expression levels.
  • Newer vectors address shortcomings of older ones, including improved safety and reduced immunogenicity.
  • Recent patents reflect significant progress in virus vector technology.

Conclusions:

  • Virus expression vectors continue to evolve with enhanced attributes.
  • Innovations span both plant and animal virus systems.
  • These advanced vectors hold significant promise for future medical research and therapeutic applications.